Wed, Apr 16, 2014, 11:01 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • beachinv beachinv Mar 11, 2013 2:29 PM Flag

    We all know what is coming....

    For those who have done more than speculate and look into the drug platform and delivery - they will have conviction to make the real money here. If you analyze the assets you will understand that Arikace is only the start to other possible drug applications using this delivery. Of course the market for Arikace will more than give us 4x our current share price. You can do your diligence and analysis - we know that this drug amikacin has already been FDA approved to treat bacterial infections so these studies is not a long shot to show efficacy as it already has been shown to work. Thus the probability for success in the upcoming trials is quite high. Look we are not trying to develop a novel drug to cure cancers here people. We are delivering an existing drug shown to fight bacterial infections and applying it to a concentrated more direct delivery (liposomal amikacin) to treat pulmonary infections. Do you work analyze risk/reward and you will have a good understanding why we have a high probability of success. Any way you look at it this should be valued at much higher prices...=)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Don't try and overanalyze here...When it comes down to it - we are just applying an approved product to for a more concentrated direct delivery (liposamal amikacin). You can debate it but I think we can agree that this has a very high probability of success in upcoming trials based on previous Phase 2 data. Do your homework then you will feel very comfortable with this investment....=)

 
INSM
12.53-0.04(-0.32%)Apr 16 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Google Inc.
NasdaqGSWed, Apr 16, 2014 4:00 PM EDT